INNOVUS PHARMACEUTICALS, INC. Advertising Expense
INNOVUS PHARMACEUTICALS, INC. reported Advertising Expense of $2.30 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2019-11-14
- INNOVUS PHARMACEUTICALS, INC. advertising expense for the quarter ending 2019-09-30 was $2.30M, a 46.51% decline year-over-year.
- INNOVUS PHARMACEUTICALS, INC. advertising expense for the quarter ending 2019-06-30 was $2.10M, a 53.33% decline year-over-year.
- INNOVUS PHARMACEUTICALS, INC. advertising expense for the quarter ending 2019-03-31 was $2.00M, a 20.00% decline year-over-year.
- INNOVUS PHARMACEUTICALS, INC. advertising expense for the quarter ending 2018-12-31 was $2.60M, a 34.61% decline year-over-year.
- INNOVUS PHARMACEUTICALS, INC. advertising expense for fiscal 2018 was $14.10M, a 161.11% increase from fiscal 2017.
- INNOVUS PHARMACEUTICALS, INC. advertising expense for fiscal 2017 was $5.40M.
| Period end | Advertising Expense 3 month | Advertising Expense 3 month as first filed | Advertising Expense 6 month | Advertising Expense 6 month as first filed | Advertising Expense 9 month | Advertising Expense 12 month |
|---|---|---|---|---|---|---|
| 2019-09-30 | $2.30M 10-Q · filed 2019-11-14 | $4.40M derived: sum of 2 quarters · filed 2019-11-14 | $6.40M 10-Q · filed 2019-11-14 | $9.00M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2019-06-30 | $2.10M 10-Q · filed 2019-08-13 | $4.10M 10-Q · filed 2019-08-13 | $6.70M derived: sum of 3 quarters · filed 2019-08-13 | $11.00M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2019-03-31 | $2.00M 10-Q · filed 2019-05-15 | $4.60M derived: sum of 2 quarters · filed 2019-05-15 | $8.90M derived: sum of 3 quarters · filed 2019-11-14 | $13.40M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $6.90M derived: sum of 2 quarters · filed 2019-11-14 | $11.40M derived: sum of 3 quarters · filed 2019-11-14 | $14.10M 10-K · filed 2019-04-01 | ||
| 2018-09-30 | $4.30M 10-Q · filed 2019-11-14 | $8.80M derived: sum of 2 quarters · filed 2019-11-14 | $11.50M 10-Q · filed 2019-11-14 | $15.28M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | $4.50M 10-Q · filed 2019-08-13 | $4.35M 10-Q · filed 2018-08-14 | $7.20M 10-Q · filed 2019-08-13 | $7.17M 10-Q · filed 2018-08-14 | $10.98M derived: sum of 3 quarters · filed 2019-08-13 | $12.33M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $2.50M 10-Q · filed 2019-05-15 | $2.53M 10-Q · filed 2018-05-14 | $6.48M derived: sum of 2 quarters · filed 2019-05-15 | $7.83M derived: sum of 3 quarters · filed 2019-05-15 | $9.08M derived: sum of 4 quarters · filed 2019-05-15 | |
| 2017-12-31 | $3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $5.33M derived: sum of 2 quarters · filed 2019-04-01 | $6.58M derived: sum of 3 quarters · filed 2019-04-01 | $5.40M 10-K · filed 2019-04-01 | ||
| 2017-09-30 | $1.35M 10-Q · filed 2017-11-14 | $2.60M derived: sum of 2 quarters · filed 2018-08-14 | $1.42M 10-Q · filed 2017-11-14 | |||
| 2017-06-30 | $1.25M 10-Q · filed 2018-08-14 | $1.25M 10-Q · filed 2017-08-14 | $2.61M 10-Q · filed 2018-08-14 | $2.61M 10-Q · filed 2017-08-14 | ||
| 2017-03-31 | $1.36M 10-Q · filed 2018-05-14 | |||||
| 2016-09-30 | $3.96M 10-Q · filed 2017-11-14 | $4.13M derived: sum of 2 quarters · filed 2017-11-14 | $1.60M 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | $169.00K 10-Q · filed 2017-08-14 | $180.00K 10-Q · filed 2017-08-14 | ||||
| 2016-03-31 | $11.00K 10-Q · filed 2017-05-15 |